Literature DB >> 20541055

ACR Appropriateness Criteria: single brain metastasis.

John H Suh, Gregory M M Videtic, Amr M Aref, Isabelle Germano, Brian J Goldsmith, Joseph P Imperato, Karen J Marcus, Michael W McDermott, Mark W McDonald, Roy A Patchell, H Ian Robins, C Leland Rogers, Aaron H Wolfson, Franz J Wippold, Laurie E Gaspar.   

Abstract

Single brain metastasis represents a common neurologic complication of cancer. Given the number of treatment options that are available for patients with brain metastasis and the strong opinions that are associated with each option, appropriate treatment for these patients has become controversial. Prognostic factors such as recursive partitioning analysis and graded prognostic assessment can help guide treatment decisions. Surgery, whole brain radiation therapy (WBRT), stereotactic radiosurgery or combination of these treatments can be considered based on a number of factors. Despite Class I evidence suggestive of best therapy, the treatment recommendation is quite varied among physicians as demonstrated by the American College of Radiology's Appropriateness Panel on single brain metastasis. Given the potential concerns of the neurocognitive effects of WBRT, the use of SRS alone or SRS to a resection cavity has gained support. Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors. Enrollment of patients onto clinical trials is important to advance our understanding of brain metastasis. Copyright 2010 American College of Radiology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541055     DOI: 10.1016/j.currproblcancer.2010.04.003

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  15 in total

Review 1.  Management of brain metastasis: past lessons, modern management, and future considerations.

Authors:  Eugene Koay; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.

Authors:  Anthony Pham; Menachem Z Yondorf; Bhupesh Parashar; Ronald J Scheff; Susan C Pannullo; Rohan Ramakrishna; Philip E Stieg; Theodore H Schwartz; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2015-12-09       Impact factor: 4.130

3.  Hippocampal-avoidance whole-brain radiation therapy: a new standard for patients with brain metastases?

Authors:  John H Suh
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

4.  Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.

Authors:  Rajal A Patel; Derrick Lock; Irene B Helenowski; James P Chandler; Matthew C Tate; Orin Bloch; Sean Sachdev; Tim J Kruser
Journal:  J Neurooncol       Date:  2018-08-06       Impact factor: 4.130

5.  Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?

Authors:  Neil C Estabrook; Stephen T Lutz; Cynthia S Johnson; Simon S Lo; Mark A Henderson
Journal:  CNS Oncol       Date:  2016-03-17

Review 6.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

7.  Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.

Authors:  Rajal A Patel; Jonathan B Bell; Thomas Kim; Mark Agulnik; James P Chandler; Bharat B Mittal; Tim J Kruser
Journal:  J Neurooncol       Date:  2017-05-25       Impact factor: 4.130

8.  Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies.

Authors:  C Nieder; N H Andratschke; H Geinitz; A L Grosu
Journal:  Strahlenther Onkol       Date:  2012-04-26       Impact factor: 3.621

9.  Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries.

Authors:  Deborah C Marshall; Logan P Marcus; Teddy E Kim; Brandon A McCutcheon; Steven J Goetsch; Takao Koiso; John F Alksne; Kenneth Ott; Bob S Carter; Jona A Hattangadi-Gluth; Masaaki Yamamoto; Clark C Chen
Journal:  J Neurooncol       Date:  2016-03-07       Impact factor: 4.130

Review 10.  Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases.

Authors:  Yu Yang Soon; Ivan Weng Keong Tham; Keith H Lim; Wee Yao Koh; Jiade J Lu
Journal:  Cochrane Database Syst Rev       Date:  2014-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.